This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe Spring
3 days in-person. 3 days virtually.
March 20–22, 2023 | Basel, SwitzerlandMarch 28–30, 2023 | Digital

Alessandro Toniolo
Chief Executive Officer at Resalis Therapeutics


After a PhD in theoretical chemistry and multiple years spent in academic research in Urbana-Champaign (IL, USA) and Milan and Pisa (Italy), AT moves to the pharmaceutical business where he gains 20 years experience in strategy and commercial roles at local and international level in several therapeutic areas including Oncology, Hematology, Immunology, Rare diseases, Respiratory, Dermatology. He operated in different organizations such as Merck, Pfizer, Novartis. He joined Resalis Therapeutics in October 2022 to accelerate the company development from research to FIH development.

AT is also engaged in biotech business through Italian Angels for Growth (IAG) particularly serving as champion for three Oncology biotech companies

Agenda Sessions

  • The obesity marketplace is heating up